How does Anticoagulant Citrate Phosphate Dextrose Adenine actually keep blood from clotting and red cells alive?
CPDA-1 works three ways: citrate binds calcium (which clotting needs), phosphate buffers acidity, and adenine fuels red cell energy during cold storage, extending shelf life from 21 to 35 days [3].
Citrate is a chelating agent—it grabs calcium ions and locks them away so the clotting cascade can't start [3]. Phosphate keeps the blood's pH stable during storage, preventing acid buildup that damages cells. Dextrose (sugar) feeds red cells' metabolism, and adenine (a nucleotide building block) replenishes ATP energy, so cells stay plump and flexible instead of shrinking and rupturing [3].
Inside a red blood cell, adenine is converted to ATP through the salvage pathway, a biochemical shortcut that recycles nucleotides [2]. This ATP powers the sodium-potassium pump, which keeps water and electrolytes balanced inside the cell. Without adenine, cold-stored red cells lose ATP, shrivel, and leak hemoglobin—a process called hemolysis that makes the blood unusable [3].
In real-world blood banks, CPDA-1 extends usable shelf life from 21 days (CPD alone) to 35 days, reducing waste and improving availability for emergency transfusions [3]. The trade-off is cost: CPDA-1 containers run $222.24 retail versus $2.03 Medicare benchmark, reflecting sterile manufacturing and cold-chain logistics [10]. Patients with G6PD deficiency (a genetic enzyme defect) cannot receive adenine-supplemented blood without specialist approval, because adenine can trigger hemolysis in their red cells [9].
Ask your blood bank or surgeon: 'Is my blood being collected into CPDA-1 or a newer additive solution?' Knowing the anticoagulant helps you understand shelf life and whether any genetic screening (like G6PD testing) is needed before donation or transfusion.